Tyro Payments Limited

The Business

Tyro is an Australian SME payments acquirer holding its own banking licence, a structure most fintech competitors lack. Payments processing across 77,800 merchants generates the large majority of gross profit, built on 580+ certified integrations with point-of-sale software used by hospitality, retail and health businesses. A banking arm layered on top, deposits and merchant lending, contributes 7% of gross profit but is growing fastest. Health claiming is the standout niche: Tyro holds an estimated 35-40% share of GP claiming volumes, a business banks have little incentive to replicate.

Recent Performance

Gross profit grew 5.3% in FY26 to $231.8 million, building on 4.4% growth the prior year, a modest acceleration but still below the roughly 5% growth rate of the broader card payments market. EBITDA margins reached an all-time high of 28.9%, as scale leverage offset wage inflation. The share price has traded broadly sideways over the past year, reflecting a market still digesting a full leadership turnover and awaiting clarity on the surcharging ban.

Outlook

Gross profit growth is expected to hold near current levels through the next two years before moderating slightly, as a declining Bendigo Bank alliance volume drag offsets core merchant growth. EBITDA margins are expected to peak in the coming years before beginning a gradual reversion toward a lower terminal level, consistent with rising competitive intensity from bank-owned acquirers. The tax rate normalises from an unusually low level toward a standard corporate rate over the next few years, so net profit growth will lag EBIT growth noticeably over that period. Investors should look through headline net profit growth in the near term to the EBITDA and free cash flow lines for a cleaner read on underlying momentum.

Key Risks

The surcharging ban could compress acquirer margins as merchants renegotiate and banks undercut on price, a risk that is genuinely bimodal rather than one-directional: integrated providers could equally differentiate on value if merchants prove willing to pay for workflow integration once surcharges disappear. Transaction volume growth of 2.9% in FY26 against roughly 5% industry growth points to gradual competitive share loss rather than a market-wide slowdown. Escalating investment from CBA and NAB in SME acquiring technology could erode Tyro's integration advantage over a multi-year horizon, though this is a slower-moving risk than the regulatory catalyst ahead.

What to Watch

The thesis-defining event is the surcharging ban's implementation in October 2026, which will determine whether integration depth becomes a genuine competitive advantage or a cost banks can undercut. First confirmation arrives with H1 FY27 results in February 2027. A capital return announcement, addressing $145 million of excess capital sitting idle on the balance sheet, would be a separate positive catalyst.

• October 2026 Surcharging ban implementation — removes merchants' ability to pass on card costs, with plausible outcomes ranging from margin compression to competitive differentiation for integrated providers.
• February 2027 H1 FY27 results — the first reporting period to reveal the post-ban take rate, resolving the margin question within roughly 12 months.
• 12-24 months Capital return decision — a buyback or special dividend would crystallise value currently sitting idle in $145 million of excess regulatory capital.

Company Description

Tyro Payments is an Australian merchant acquirer and authorised deposit-taking institution serving 77,800 small and medium businesses. The core payments business processes card transactions across hospitality (roughly 41% of transaction value), retail (24%) and health (18%), integrated directly into 580+ certified point-of-sale systems. This integration layer, not just the payment terminal, is what differentiates Tyro from bank-owned acquirers offering standalone hardware. A banking division sits alongside payments, taking deposits and extending merchant cash advances secured against future transaction volumes, currently 7% of gross profit but the fastest-growing segment. A smaller corporate treasury function invests surplus capital. Health claiming, run through the GapOnly product, is a distinct sub-business with its own competitive dynamics separate from general merchant acquiring.

Where the Growth Is

Banking, comprising deposit-taking and merchant lending, is the standout growth engine, expanding gross profit 23% in FY26 off a base that itself grew strongly the year before. This pace should decelerate as the loan book matures, moderating toward high single-digit growth by the end of the decade, but banking's contribution to total gross profit should still roughly double from today's 7%. The mechanism matters as much as the growth rate: merchants who also bank with Tyro show materially higher retention, meaning banking cross-sell strengthens the core payments franchise rather than operating as a standalone side business.

Competitive Position

Tyro's advantage rests on integration depth rather than scale. Two decades of building certified connections into practice management and point-of-sale software create real switching costs: merchants using three or more integrations churn at roughly half the rate of single-integration merchants, and Tyro sustains a merchant retention rate above 96%. This supports a 15-20 basis point take rate premium over bank-owned acquirers, who typically sell standalone terminals without the workflow integration. Market share sits at an estimated 4-5% of Australian card acquiring, a figure that has been broadly stable rather than expanding, which is itself informative: the moat is defensive, protecting an existing niche, rather than a platform for taking share from the major banks. Health claiming is the exception, where an estimated 35-40% share reflects genuine domain specialisation that banks have shown little appetite to replicate. This competitive position looks narrow but durable for roughly the next five years, assuming bank investment in acquiring technology continues at its current pace.

Management & Capital Discipline

The leadership team turned over entirely in the past year: the CEO, chief operating officer and chief growth officer all have less than 12 months in their roles. Industry credentials are strong, but there is no Tyro-specific execution track record to assess. On capital, the balance sheet holds $145 million in available capital beyond regulatory requirements, funded by zero debt, yet management has not articulated a framework for returning this capital despite it currently earning a return below the company's cost of capital. One observation worth flagging directly: management's public commentary on the surcharging ban consistently frames it as a competitive opportunity without acknowledging the plausible scenario in which it compresses margins, a gap in disclosure rather than a factual misstatement.

Financial Position

Tyro holds zero debt and a regulatory capital ratio of 76.5%, roughly seven times the minimum required of an authorised deposit-taking institution. Available own funds of $145 million sit alongside a further $97 million investment portfolio and $31 million in term deposits, providing a substantial buffer against a downturn in small business trading conditions. Free cash flow turned solidly positive in FY26 at $29.4 million and is forecast to keep growing through the outlook period. The company could absorb an extended SME recession without any solvency concern, a rare position of strength for a business this size in a competitive niche.